We performed a prospective random study to assess possible thyroid stunning by a 185-
MBq iodine-131 dose used to diagnose thyroid remnants. Patients with differentiated thyroid …

Objectives Radioiodine ablation of thyroid tissue remains the cornerstone of treatment for
patients with differentiated thyroid carcinoma after thyroidectomy. Selecting an optimal dose …

Purpose To evaluate the predictive capacity of clinical and laboratory variables in relation to
the success of ablation. The variables studied were as follows: thyroglobulin (Tg) in …

Thyroid cancer is uncommon, with an incidence of 10,300 new patients each year and a
mortality of 1,100 patients each year. Patient survival correlates with many factors, including …

Introduction The aim of the study was to compare the success rate of an uptake-related
ablation protocol in which the dose depends on an I-131 24-h neck uptake measurement …

This study seeks to evaluate the role of radioiodine in the ablation of the remaining thyroid
lobe, following a histopathological diagnosis of minimally invasive follicular carcinoma or …

The biological elimination of therapeutic 131 I in patients with differentiated thyroid cancer
(DTC), post total or near-total thyroidectomy, was compared after withholding levothyroxine …

The aim of the study was to assess whether stimulation by recombinant human TSH (rhTSH)
may be used in patients with differentiated thyroid carcinoma for postsurgical ablation of …

Objectives Currently, little is known about the prognostic significance of achieving successful
ablation with the first dosage of I-131 in patients with differentiated thyroid cancer. This study …

Previous studies demonstrated that preparation with recombinant human thyroid-stimulating
hormone (rhTSH) for thyroid remnant ablation results in lower extrathyroidal radiation …